CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported a loss of $1.9 million in its second quarter.
The Chicago-based company said it had a loss of 1 cent per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.
The company posted revenue of $71.5 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $65 million.
Xeris Biopharma expects full-year revenue in the range of $280 million to $290 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
